Literature DB >> 3367086

Potential bile acid metabolites. 13. Improved routes to 3 beta, 6 beta- and 3 beta, 6 alpha-dihydroxy-5 beta-cholanoic acids.

T Iida1, T Momose, T Tamura, T Matsumoto, F C Chang, J Goto, T Nambara.   

Abstract

New synthetic routes to three possible stereoisomers of hyodeoxycholic (3 alpha, 6 alpha-dihydroxy-5 beta-cholanic) acid are described. The principal reactions involved were inversion at C-3 of 3 alpha-hydroxy-6-oxo derivatives with diethyl azodicarboxylate-triphenylphosphine-formic acid and with N,N-dimethylformamide, without allomerization to the more stable 5 alpha form. On the basis of physical and chromatographic data, previously reported 3 beta, 6 alpha-dihydroxy-5 beta-cholanic acid and its methyl ester are shown to be C-3 epimeric mixtures. The 13C nuclear magnetic resonance spectra were of key importance in characterizing the stereoisomers and estimating their purity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3367086

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  3 in total

Review 1.  Chemical and metabolic transformations of selected bile acids.

Authors:  K Kuhajda; S Kevresan; J Kandrac; J P Fawcett; M Mikov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jul-Sep       Impact factor: 2.441

2.  Potential bile acid metabolites. 24. An efficient synthesis of carboxyl-linked glucosides and their chemical properties.

Authors:  Takashi Lida; Ryusei Nakamori; Rie Yabuta; Satoru Yada; Yuzuru Takagi; Nariyasu Mano; Shigeo Ikegawa; Junichi Goto; Toshio Nambara
Journal:  Lipids       Date:  2002-01       Impact factor: 1.880

3.  Marine and semi-synthetic hydroxysteroids as new scaffolds for pregnane X receptor modulation.

Authors:  Valentina Sepe; Francesco Saverio Di Leva; Claudio D'Amore; Carmen Festa; Simona De Marino; Barbara Renga; Maria Valeria D'Auria; Ettore Novellino; Vittorio Limongelli; Lisette D'Souza; Mahesh Majik; Angela Zampella; Stefano Fiorucci
Journal:  Mar Drugs       Date:  2014-05-27       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.